Polymer compounds

The bioelectrode composition, using a complex of ionic polymer material and particles, addresses conductivity and biocompatibility issues in wearable devices, ensuring stable signal transmission and preventing skin allergies, while being lightweight and cost-effective.

JP7577883B2Active Publication Date: 2024-11-05SHIN ETSU CHEMICAL CO LTD
View PDF 11 Cites 0 Cited by

Patent Information

Application Number
JP2024059145
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Priority Date
2021-01-04
Filing Date
2024-04-01
Publication Date
2024-11-05
Estimated Expiration
2041-09-17

AI Technical Summary

Technical Problem

Existing bioelectrodes used in wearable devices face challenges such as loss of conductivity due to drying, skin allergies from certain materials, and the need for both high conductivity and biocompatibility, while also requiring adhesion and flexibility to maintain consistent contact with the skin.

Method used

A bioelectrode composition comprising a complex of ionic polymer material and particles, with specific salts and structures, bonded to a polymer, and optionally combined with adhesive resins and conductive powders, to form a biocontact layer that maintains conductivity and biocompatibility, even when wet or dry.

Benefits of technology

The bioelectrode composition ensures stable electrical signal transmission with high sensitivity and biocompatibility, preventing skin allergies and maintaining conductivity over time, while being lightweight and cost-effective.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007577883000118
    Figure 0007577883000118
  • Figure 0007577883000119
    Figure 0007577883000119
  • Figure 0007577883000120
    Figure 0007577883000120
Patent Text Reader

Abstract

To provide a polymer compound capable of forming a living body contact layer for a bio-electrode which offers excellent electric conductivity and biocompatibility, is light in weight, and can be manufactured at low cost, without experiencing a significant reduction in electric conductivity even when wetted with water or dried.SOLUTION: The present invention provides a polymer compound that comprises a repeating unit having a structure selected from ammonium, lithium, sodium, potassium, and silver salts of N-carbonyl fluorosulfonamide, and a repeating unit having an alkoxysilyl group, with a weight average molecular weight ranging from 1,000 to 1,000,000.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a bioelectrode that can be brought into contact with the skin of a living body and detect a bodily condition such as heart rate by an electrical signal from the skin, a method for producing the same, a bioelectrode composition that is suitably used for the bioelectrode, and a polymer compound that is used for the composition. [Background technology]

[0002] In recent years, the development of wearable devices has progressed with the spread of IoT (Internet of Things). Typical examples are watches and glasses that can connect to the Internet. In addition, wearable devices that can constantly monitor the condition of the body are needed in the medical and sports fields, and these are expected to be growth fields in the future.

[0003] In the medical field, wearable devices that monitor the state of the body's organs by sensing weak currents, such as in electrocardiograms, which detect the movement of the heart through electrical signals, are being considered. In electrocardiograms, electrodes coated with conductive paste are attached to the body to perform the measurement, but this is a one-time, short-term measurement. In contrast, the aim of developing medical wearable devices such as those mentioned above is to develop devices that constantly monitor the health state for several weeks in a row. Therefore, the bioelectrodes used in medical wearable devices are required to have no change in conductivity even when used for long periods of time and to be free of skin allergies. In addition to these, they are also required to be lightweight and to be able to be manufactured at low cost.

[0004] Wearable medical devices include those that are attached to the body and those that are incorporated into clothing. As a type that is attached to the body, a bioelectrode that uses a water-soluble gel containing water and electrolytes, which are the materials for the conductive paste mentioned above, has been proposed (Patent Document 1). The water-soluble gel contains sodium, potassium, and calcium as electrolytes in a water-soluble polymer that holds water, and converts changes in ion concentration from the skin into electricity. On the other hand, as a type that is incorporated into clothing, a method has been proposed in which a conductive polymer such as PEDOT-PSS (Poly-3,4-ethylenedioxythiophene-Polystyrenesulfonate) or cloth with silver paste incorporated into the fibers is used as an electrode (Patent Document 2).

[0005] However, when using the above-mentioned water-soluble gel containing water and electrolytes, there is a problem that the conductivity is lost when the water dries out. On the other hand, when using metals with a high ionization tendency such as copper, there is a problem that some people may develop skin allergies, and when using conductive polymers such as PEDOT-PSS, there is a problem that the conductive polymer is highly acidic and therefore may develop skin allergies, and the conductive polymer may peel off from the fibers during washing.

[0006] In addition, because of their excellent electrical conductivity, the use of metal nanowires, carbon black, carbon nanotubes, and the like as electrode materials has also been considered (Patent Documents 3, 4, 5). Metal nanowires have a high probability of contact between wires, so they can conduct electricity with a small amount of additive. However, metal nanowires are thin materials with sharp tips, which can cause skin allergies. Thus, even if the material itself does not cause an allergic reaction, the shape and irritation of the material can cause the material to have poor biocompatibility, making it difficult to achieve both electrical conductivity and biocompatibility.

[0007] Metal films are highly conductive and one would think they would function as excellent bioelectrodes, but this is not necessarily the case. When the heart beats, not only a weak current is released from the skin, but also sodium ions, potassium ions, and calcium ions. For this reason, it is necessary to convert the change in ion concentration into an electric current, but precious metals, which are difficult to ionize, are inefficient at converting ions from the skin into an electric current. Therefore, bioelectrodes using precious metals have a high impedance, and there is a high resistance to electrical current passing through the skin.

[0008] On the other hand, batteries to which ionic liquids have been added are being considered (Patent Document 6). Ionic liquids are characterized by high thermal and chemical stability and excellent electrical conductivity, and are being widely used in batteries. However, since ionic liquids with small molecular weights as shown in Patent Document 6 dissolve in water, when a bioelectrode to which this has been added is used, the ionic liquid is extracted by sweat from the skin, which not only reduces electrical conductivity but also penetrates the skin and causes rough skin.

[0009] In addition, a battery using a lithium salt of a polymer-type sulfonimide is being studied (Non-Patent Document 1). However, although lithium is applied to batteries because of its high ion mobility, it is not a biocompatible material. Furthermore, a lithium salt of fluorosulfonic acid pendant on silicone is also being studied (Non-Patent Document 2).

[0010] When the bioelectrode is separated from the skin, it is no longer able to obtain information from the body. Furthermore, even a change in the contact area causes a fluctuation in the amount of electricity passing through, and the baseline of the electrocardiogram (electrical signal) fluctuates. Therefore, in order to obtain a stable electrical signal from the body, it is necessary for the bioelectrode to be in constant contact with the skin and for the contact area to remain constant. For this reason, it is preferable for the bioelectrode to have adhesive properties. It is also necessary for the bioelectrode to have elasticity and flexibility so that it can follow the expansion and contraction and bending changes of the skin.

[0011] A bioelectrode is being considered in which the part that comes into contact with the skin is made of silver chloride, and the part that conducts to the device is laminated with silver. Solid silver chloride has no adhesive power to the skin and is not elastic, so its ability to collect biosignals decreases, especially when the human body moves. For this reason, a laminated film of silver chloride and silver is used as a bioelectrode with a water-soluble gel laminated between the skin. In this case, the aforementioned gel will dry out and cause deterioration.

[0012] In recent years, surface-modified functional silica has been developed. For example, a silicone rubber material has been proposed to which silica with phosphate pendants on the surface is added in order to prevent static electricity in toner for printers (Patent Document 7). The silica surface is modified by reacting a trialkoxysilane compound having phosphate with the silica surface. [Prior art documents] [Patent documents]

[0013] [Patent Document 1] International Publication No. WO2013-039151 [Patent Document 2] JP 2015-100673 A [Patent Document 3] Japanese Patent Application Publication No. 5-095924 [Patent Document 4] JP 2003-225217 A [Patent Document 5] JP 2015-019806 A [Patent Document 6] Special Publication No. 2004-527902 [Patent Document 7] JP 2020-033224 A [Non-patent literature]

[0014] [Non-Patent Document 1] J.Mater.Chem.A,2016,4,p10038-10069 [Non-Patent Document 2] J. of the Electrochemical Society, 150(8) A1090-A1094 (2003) Summary of the Invention [Problem to be solved by the invention]

[0015] The present invention has been made to solve the above problems, and aims to provide a bioelectrode composition capable of forming a biocontact layer for a bioelectrode that has excellent electrical conductivity and biocompatibility, is lightweight, can be produced at low cost, and does not significantly decrease in conductivity whether wetted with water or dried; a bioelectrode in which a biocontact layer is formed from the bioelectrode composition; and a method for producing the same. [Means for solving the problem]

[0016] In order to solve the above problems, the present invention provides A bioelectrode composition comprising: (A) a complex of an ionic polymer material and a particle; The component (A) contains particles bonded to a polymer having a repeating unit having a structure selected from the group consisting of the ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide.

[0017] Such a bioelectrode composition can provide a bioelectrode composition capable of forming a biocontact layer for a bioelectrode that has excellent electrical conductivity and biocompatibility, is lightweight, and can be produced at low cost, and whose electrical conductivity does not decrease significantly whether it is wetted with water or dried.

[0018] Moreover, it is preferable that the particles have a diameter of 2 nm to 50 μm.

[0019] It is also preferable that the particles are any of silicon material particles, alumina particles, titania particles, zirconia particles, lithium titanate particles, hafnium oxide particles, zinc oxide particles, germanium particles, germanium oxide particles, tin particles, tin oxide particles, antimony oxide particles, strontium oxide particles, tungsten oxide particles, bismuth oxide particles, yttrium oxide particles, ytterbium oxide particles, gadolinium oxide particles, indium oxide particles, molybdenum oxide particles, and scandium oxide particles.

[0020] Such particles can be suitably used.

[0021] In addition, it is preferable that the repeating unit having a structure selected from the group consisting of the ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide has a structure represented by any of the following general formulas (1)-1 to (1)-4. [ka] (In the formula, Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group. When Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are one oxygen atom bonding to one carbon atom to form a carbonyl group. Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group. At least one of Rf1 to Rf4 is a fluorine atom or a trifluoromethyl group. Rf5, Rf6, and Rf7 are a fluorine atom or a linear or branched alkyl group having 1 to 4 carbon atoms and having at least one fluorine atom. m is an integer of 1 to 4. M + is an ion selected from ammonium ion, lithium ion, sodium ion, potassium ion, and silver ion.

[0022] In addition, the repeating unit having a structure selected from the ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide is preferably one or more selected from repeating units a1 to a7 represented by the following general formula (2). [ka] (In the formula, R 1 , R 3 , R 5 , R 8 , R 10 , R 11 and R 13 are each independently a hydrogen atom or a methyl group, R 2 , R 4 , R 6 , R 9 , R 12 and R 14 R each independently represents a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms which may have either an ester group or an ether group, or both. 7 is a linear or branched alkylene group having 1 to 4 carbon atoms; R 7 In the formula, one or two of the hydrogen atoms may be substituted with a fluorine atom. Each of X1, X2, X3, X4, X6, and X7 is independently a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group, and X5 is a single bond, an ether group, or an ester group. Y is an oxygen atom, -NR 19 - group, and R 19 is a hydrogen atom or a linear or branched alkyl group having 1 to 4 carbon atoms; R 4 may be bonded to form a ring. m is an integer of 1 to 4. a1, a2, a3, a4, a5, a6, and a7 each satisfy 0≦a1≦1.0, 0≦a2≦1.0, 0≦a3≦1.0, 0≦a4≦1.0, 0≦a5≦1.0, 0≦a6≦1.0, and 0≦a7≦1.0, <a1+a2+a3+a4+a5+a6+a7≦1.0である。M +is an ion selected from an ammonium ion, a lithium ion, a sodium ion, a potassium ion, and a silver ion. Rf5, Rf6, and Rf7 are a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and have at least one fluorine atom.

[0023] Furthermore, it is preferable that the component (A) is obtained by reacting particles with a polymer having an alkoxysilyl group, which is copolymerized with a repeating unit represented by the following general formula (4) in addition to the repeating unit represented by the general formula (2). [ka] (In the formula, R 20 is a hydrogen atom or a methyl group, X8 is a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group, R 21 R is a single bond, a linear, branched or cyclic alkylene group having 1 to 10 carbon atoms, or a phenylene group, which may contain an oxygen atom or a nitrogen atom. 22 are the same or different alkyl groups having 1 to 4 carbon atoms. b is 0 <b<1.0である。)

[0024] It is also preferred that the particles in the component (A) are silicon material particles, and that the component (A) is obtained by reacting 100 parts by mass of silicon material particles with 5 parts by mass or more of the polymer having an alkoxysilyl group.

[0025] Furthermore, the component (A) preferably contains, as the ammonium ion constituting the ammonium salt, an ammonium ion represented by the following general formula (3). [ka] (In the formula, R 101d , R 101e , R 101f , R 101gR is a hydrogen atom, a linear, branched, or cyclic alkyl group having 1 to 14 carbon atoms, a linear, branched, or cyclic alkenyl or alkynyl group having 2 to 12 carbon atoms, or an aromatic group having 4 to 20 carbon atoms, and may have one or more groups selected from an ether group, a carbonyl group, an ester group, a hydroxy group, an amino group, a nitro group, a sulfonyl group, a sulfinyl group, a halogen atom, and a sulfur atom. 101d and R 101e , R 101d and R 101e and R 101f may form a ring together with the nitrogen atom to which they are attached, and when they form a ring, R 101d and R 101e and R 101d and R 101e and R 101f is an alkylene group having 3 to 10 carbon atoms, or forms a heteroaromatic ring having the nitrogen atom in the ring.

[0026] In such a bioelectrode composition, the ionic polymer is pendant on the particle surface, so that the skin permeability is reduced and the skin irritation is reduced, so that it is possible to prevent the ionic polymer from passing through the skin and causing allergies. Furthermore, the ionic polymer is attached to the particle surface, so that an ion conductive path is formed on the particle surface, and the sensitivity of the bioelectrode can be increased.

[0027] It is preferable that the adhesive composition further contains a tackifying resin as component (B).

[0028] The component (B) is preferably at least one selected from a silicone resin, a (meth)acrylate resin, and a urethane resin.

[0029] Such a device can be in constant contact with the skin and can provide a stable electrical signal for a long period of time.

[0030] The component (B) preferably contains a diorganosiloxane having an alkenyl group and an organohydrogenpolysiloxane having a SiH group.

[0031] The component (B) further includes R x SiO (4-x) / 2 It is preferable that the silicone resin contains a silicone resin having a unit (R is a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, and x is in the range of 2.5 to 3.5) and a SiO2 unit.

[0032] Such a composition can be suitably used as a bioelectrode composition.

[0033] Furthermore, the component (C) preferably contains a polymeric compound having an ionic repeating unit.

[0034] In addition, it is preferable that the ionic repeating unit of the component (C) contains a repeating unit having a structure selected from the group consisting of the ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide, as represented by the following general formula (2): [ka] (In the formula, R 1 , R 3 , R 5 , R 8 , R 10 , R 11 and R 13 are each independently a hydrogen atom or a methyl group, R 2 , R 4 , R 6 , R 9 , R 12 and R 14 R each independently represents a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms which may have either an ester group or an ether group, or both. 7 is a linear or branched alkylene group having 1 to 4 carbon atoms; R 7In the formula, one or two of the hydrogen atoms may be substituted with a fluorine atom. Each of X1, X2, X3, X4, X6, and X7 is independently a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group, and X5 is a single bond, an ether group, or an ester group. Y is an oxygen atom, -NR 19 - group, and R 19 is a hydrogen atom or a linear or branched alkyl group having 1 to 4 carbon atoms; R 4 may be bonded to form a ring. m is an integer of 1 to 4. a1, a2, a3, a4, a5, a6, and a7 each satisfy 0≦a1≦1.0, 0≦a2≦1.0, 0≦a3≦1.0, 0≦a4≦1.0, 0≦a5≦1.0, 0≦a6≦1.0, and 0≦a7≦1.0, <a1+a2+a3+a4+a5+a6+a7≦1.0である。M + is an ion selected from an ammonium ion, a lithium ion, a sodium ion, a potassium ion, and a silver ion. Rf5, Rf6, and Rf7 are a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and have at least one fluorine atom.

[0035] A bioelectrode composition containing a polymer compound having such a repeating unit can further improve the effects of the present invention.

[0036] Furthermore, it is preferable that the component (D) contains carbon powder and / or metal powder.

[0037] The carbon powder is preferably either or both of carbon black and carbon nanotubes.

[0038] The metal powder is preferably a metal powder selected from the group consisting of gold, silver, platinum, copper, tin, titanium, nickel, aluminum, tungsten, molybdenum, ruthenium, chromium, and indium.

[0039] The metal powder is preferably silver powder.

[0040] This will result in even better electrical conductivity.

[0041] It is preferable that the component (E) further contains an organic solvent.

[0042] In this case, the coating properties of the bioelectrode composition are further improved.

[0043] Furthermore, the present invention provides a bioelectrode having a conductive substrate and a biocontact layer formed on the conductive substrate, wherein the biocontact layer is a cured product of the bioelectrode composition.

[0044] The bioelectrode of the present invention is a bioelectrode that has excellent electrical conductivity and biocompatibility, is lightweight, can be manufactured at low cost, and does not experience a significant decrease in electrical conductivity even when wetted or dried.

[0045] In addition, the conductive substrate preferably contains one or more metals selected from gold, silver, silver chloride, platinum, aluminum, magnesium, tin, tungsten, iron, copper, nickel, stainless steel, chromium, titanium, carbon, and conductive polymers.

[0046] In the bioelectrode of the present invention, such a conductive substrate can be particularly suitably used.

[0047] Furthermore, the present invention provides a method for manufacturing a bioelectrode having a conductive substrate and a biocontact layer formed on the conductive substrate, in which the bioelectrode composition is applied to the conductive substrate and cured to form the biocontact layer.

[0048] The manufacturing method of the bioelectrode of the present invention makes it possible to easily manufacture a bioelectrode that has excellent conductivity and biocompatibility, is lightweight, and can be manufactured at low cost, and whose conductivity does not decrease significantly whether it is wetted with water or dried.

[0049] In addition, the method for manufacturing a bioelectrode preferably uses, as the conductive base material, one or more selected from gold, silver, silver chloride, platinum, aluminum, magnesium, tin, tungsten, iron, copper, nickel, stainless steel, chromium, titanium, carbon, and a conductive polymer.

[0050] In the method for producing a bioelectrode of the present invention, such a conductive substrate can be particularly suitably used.

[0051] The present invention also provides a polymer compound having a repeating unit having a structure selected from the group consisting of ammonium salts, lithium salts, sodium salts, potassium salts, and silver salts of N-carbonylfluorosulfonamide, and a repeating unit having an alkoxysilyl group, and having a weight average molecular weight in the range of 1,000 to 1,000,000.

[0052] It is preferable that the repeating unit having a structure selected from the group consisting of ammonium salts, lithium salts, sodium salts, potassium salts, and silver salts of N-carbonylfluorosulfonamide is a repeating unit a7 represented by the following general formula (5), and the repeating unit having an alkoxysilyl group is a repeating unit b represented by the following general formula (5). [ka] (In the formula, R 13 are each independently a hydrogen atom or a methyl group, R 14 are each independently a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms which may have either an ester group or an ether group, or both. X7 are each independently a single bond, a phenylene group, a naphthylene group, an ether group, an ester group or an amide group, and M + Rf7 is an ion selected from an ammonium ion, a lithium ion, a sodium ion, a potassium ion, and a silver ion. Rf7 is a fluorine atom or a linear or branched alkyl group having 1 to 4 carbon atoms and has at least one fluorine atom. 20 is a hydrogen atom or a methyl group, and X8 is a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group, and R 21 R is a single bond, a linear, branched or cyclic alkylene group having 1 to 10 carbon atoms, or a phenylene group, which may contain an oxygen atom or a nitrogen atom. 22 are the same or different alkyl groups having 1 to 4 carbon atoms. a7 is 0 <a7<1.0であり、bは0<b<1.0である。)

[0053] Such an ionic polymer compound can be suitably used as the polymer compound to be bound to the particles used in the bioelectrode composition.

[0054] The present invention also provides a composite in which an ionic polymer material is bonded to a particle, the composite being a particle bonded to a polymer having a repeating unit having a structure selected from the group consisting of the ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide.

[0055] It is preferable that the complex is a particle bonded to an ionic polymer material, and the complex is a particle bonded to a polymer having a repeating unit having a structure selected from the group consisting of ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of N-carbonylfluorosulfonamide.

[0056] Moreover, it is preferable that the particles have a diameter of 2 nm to 50 μm.

[0057] Furthermore, it is preferable that the particles are any one of silicon material particles, alumina particles, titania particles, zirconia particles, lithium titanate particles, hafnium oxide particles, zinc oxide particles, germanium particles, germanium oxide particles, tin particles, tin oxide particles, antimony oxide particles, strontium oxide particles, tungsten oxide particles, bismuth oxide particles, yttrium oxide particles, ytterbium oxide particles, gadolinium oxide particles, indium oxide particles, molybdenum oxide particles, and scandium oxide particles.

[0058] By modifying the particles with an ionic polymer, the particles become particularly useful as a component of a bioelectrode composition that can form a biocontact layer for a bioelectrode that can transmit ions and electrical signals released from the skin to the device with high sensitivity and efficiency (i.e., excellent conductivity), does not cause allergies even when worn on the skin for a long period of time (i.e., excellent biocompatibility), and does not significantly decrease in conductivity whether wetted or dried. Effect of the Invention

[0059] As described above, the bioelectrode composition containing particles (composite of ionic polymer material and particles) that bind to the ionic polymer of the present invention can efficiently transmit electrical signals from the skin to the device (i.e., excellent electrical conductivity), is not likely to cause allergies even when worn on the skin for a long period of time (i.e., excellent biocompatibility), is lightweight, can be manufactured at low cost, and can form a biocontact layer for a bioelectrode that does not significantly decrease in electrical conductivity even when wet or dried. Furthermore, the electrical conductivity can be further improved by adding an ionic polymer compound or a conductive powder (carbon powder, metal powder), and a bioelectrode with particularly high adhesive strength and high elasticity can be manufactured by combining it with a resin having adhesiveness and elasticity. Furthermore, the elasticity and adhesiveness to the skin can be improved by additives, and the elasticity and adhesiveness can be adjusted by appropriately adjusting the composition of the resin and the thickness of the biocontact layer.

[0060] Furthermore, the bioelectrode of the present invention can achieve both electrical conductivity and biocompatibility due to the particles that bind to the above-mentioned ionic polymer, and since it is also adhesive, the contact area with the skin is constant, making it possible to obtain electrical signals from the skin stably and with high sensitivity.

[0061] Furthermore, the manufacturing method of the bioelectrode of the present invention makes it possible to easily manufacture, at low cost, the bioelectrode of the present invention, which has excellent conductivity and biocompatibility, is lightweight, and whose conductivity does not decrease significantly whether it is wetted with water or dried. [Brief description of the drawings]

[0062] [Figure 1] FIG. 1 is a schematic cross-sectional view showing an example of a bioelectrode of the present invention. [Diagram 2] FIG. 2 is a schematic cross-sectional view showing an example of the bioelectrode of the present invention attached to a living body. [Diagram 3] FIG. 2 is a schematic diagram of a bioelectrode produced in an example of the present invention after printing. [Figure 4] FIG. 2 is a schematic diagram showing one of the bioelectrodes produced in the examples of the present invention cut out and with an adhesive layer attached. [Diagram 5] FIG. 2 is a diagram showing the locations where electrodes and a ground are attached to the human body when measuring a biosignal in an embodiment of the present invention. [Figure 6] 1 is an electrocardiogram waveform obtained using a bioelectrode according to an embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0063] As described above, there has been a need to develop a bioelectrode composition capable of forming a biocontact layer for a bioelectrode that is excellent in electrical conductivity and biocompatibility, lightweight, and can be produced at low cost, does not significantly decrease in electrical conductivity whether wetted with water or dried, and leaves no residue on the skin after being peeled off from the skin; a bioelectrode in which a biocontact layer is formed from the bioelectrode composition; and a method for producing the same.

[0064] Sodium, potassium, and calcium ions are released from the skin surface in tandem with the heartbeat. Bioelectrodes need to convert the increase or decrease in the number of ions released from the skin into an electrical signal. To do this, materials with excellent ionic conductivity are required to transmit the increase or decrease in ions.

[0065] In order to stably obtain biosignals by attaching the electrode to the skin, the electrode film needs to be adhesive. On the other hand, if residue remains on the skin after peeling it off after a long time of attachment, it may cause rashes or rough skin. In order to prevent residue from being generated, it is necessary to make the electrode in the form of an ionic polymer bound to particles such as silica, and this led to the invention of the present invention.

[0066] The inventors propose a bioelectrode composition containing an ionic polymer material (hereinafter, the ionic polymer material is also referred to as an ionic polymer) bound to particles, and a bioelectrode formed by curing the same, as a bioelectrode composition.

[0067] When the acidity of the acid that forms the neutralized salt is high, the ions are strongly polarized, improving ionic conductivity. This is why lithium salts of bis(trifluoromethanesulfonyl)imide acid and tris(trifluoromethanesulfonyl)methide acid show high ionic conductivity in lithium-ion batteries. On the other hand, the higher the acid strength of the acid before it becomes a neutralized salt, the stronger the bioirritation of the salt. In other words, there is a trade-off between ionic conductivity and bioirritation. However, salts to be applied to bioelectrodes must have both high ionic conductivity and low bioirritation.

[0068] The larger the molecular weight of an ionic compound, the less the skin permeability and the less irritation to the skin. For this reason, the ionic compound is preferably a polymer type with a high molecular weight. Therefore, the present inventors have come up with the idea that by polymerizing this ionic compound into a form having a polymerizable double bond and further adding a complex of the ionic polymer after polymerization and particles, no residue is left even when the ionic compound is peeled off after being attached to the skin for a long time.

[0069] Furthermore, the inventors have discovered that by mixing this salt with, for example, a silicone-, acrylic-, or urethane-based adhesive (resin), the adhesive can be in constant contact with the skin and a stable electrical signal can be obtained for a long period of time.

[0070] To construct a highly sensitive bioelectrode, high ionic conductivity alone is not enough; high electronic conductivity is also necessary. Adding metal powder or carbon powder is effective in increasing electronic conductivity.

[0071] That is, the present invention provides: A bioelectrode composition comprising: (A) a complex of an ionic polymer material and a particle; The component (A) is a bioelectrode composition containing particles bonded to a polymer having a repeating unit having a structure selected from the group consisting of the ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide.

[0072] The present invention will be described in detail below, but the present invention is not limited thereto.

[0073] <Bioelectrode composition> The bioelectrode composition of the present invention contains (A) a complex of an ionic polymer material and particles, and preferably (B) an adhesive resin. Each component will be described in more detail below. In the following, the complex of the ionic polymer material and particles will be referred to as "component (A)", the adhesive resin as "component (B)", the blended ionic polymer as "component (C)", the conductive powder as "component (D)", the organic solvent as "component (E)", and other additives as "component (F)".

[0074] [(A) Complex (salt) of ionic polymer material and particle] In the bioelectrode composition of the present invention, the complex salt of (A) an ionic polymer material and a particle is a particle bound to a polymer (ionic polymer) having a repeating unit having a structure selected from the ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide. As shown in JP 2018-70775 A, the above salt is particularly preferably a salt of N-carbonylfluorosulfonamide, which has high ionic conductivity. Preferably, the above polymer further has a repeating unit having an alkoxysilyl group, and the above polymer is bound to the particle by reaction.

[0075] The structure of the ammonium salt, lithium salt, sodium salt, potassium salt, or silver salt of any of fluorosulfonic acid, fluorosulfonimide, and N-carbonylfluorosulfonamide is preferably one represented by the following general formulas (1)-1 to (1)-4. [ka] (In the formula, Rf1 and Rf2 are a hydrogen atom, a fluorine atom, an oxygen atom, a methyl group, or a trifluoromethyl group. When Rf1 and Rf2 are oxygen atoms, Rf1 and Rf2 are one oxygen atom bonding to one carbon atom to form a carbonyl group. Rf3 and Rf4 are a hydrogen atom, a fluorine atom, or a trifluoromethyl group. At least one of Rf1 to Rf4 is a fluorine atom or a trifluoromethyl group. Rf5, Rf6, and Rf7 are a fluorine atom or a linear or branched alkyl group having 1 to 4 carbon atoms and having at least one fluorine atom. m is an integer of 1 to 4. M + is an ion selected from ammonium ion, lithium ion, sodium ion, potassium ion, and silver ion.

[0076] The repeating unit having a structure selected from the ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of fluorosulfonic acid represented by general formula (1)-1 or (1)-2, sulfonimide represented by (1)-3, and N-carbonylfluorosulfonamide represented by (1)-4 is preferably one or more selected from repeating units a1 to a7 represented by general formula (2) below. [ka] (In the formula, R 1 , R 3 , R 5 , R 8 , R 10 , R 11 and R 13 are each independently a hydrogen atom or a methyl group, R 2 , R 4 , R 6 , R 9 , R 12 and R 14 R each independently represents a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms which may have either an ester group or an ether group, or both. 7 is a linear or branched alkylene group having 1 to 4 carbon atoms; R 7 In the formula, one or two of the hydrogen atoms may be substituted with a fluorine atom. Each of X1, X2, X3, X4, X6, and X7 is independently a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group, and X5 is a single bond, an ether group, or an ester group. Y is an oxygen atom, -NR 19 - group, and R 19 is a hydrogen atom or a linear or branched alkyl group having 1 to 4 carbon atoms; R 4 may be bonded to form a ring. m is an integer of 1 to 4. a1, a2, a3, a4, a5, a6, and a7 each satisfy 0≦a1≦1.0, 0≦a2≦1.0, 0≦a3≦1.0, 0≦a4≦1.0, 0≦a5≦1.0, 0≦a6≦1.0, and 0≦a7≦1.0, <a1+a2+a3+a4+a5+a6+a7≦1.0である。M +is an ion selected from an ammonium ion, a lithium ion, a sodium ion, a potassium ion, and a silver ion. Rf5, Rf6, and Rf7 are a fluorine atom, or a linear or branched alkyl group having 1 to 4 carbon atoms, and have at least one fluorine atom.

[0077] Of the repeating units a1 to a7 represented by the above general formula (2), specific examples of the fluorosulfonate monomer for obtaining the repeating units a1 to a5 are shown below.

[0078] [ka]

[0079] [ka]

[0080] [ka]

[0081] [ka]

[0082] [ka]

[0083] [ka]

[0084] [ka]

[0085] [ka]

[0086]

change

[0087]

change

[0088]

change

[0089]

change

[0090]

change

[0091]

change

[0092]

change

[0093]

change

[0094]

change

[0095]

change

[0096]

change

[0097] [ka]

[0098] [ka]

[0099] Specific examples of the sulfonimide salt monomer for obtaining the repeating unit a6 include those shown below.

[0100] [ka]

[0101] [ka]

[0102] [ka]

[0103] [ka]

[0104] [ka]

[0105] Specific examples of N-carbonylfluorosulfonamide salt monomers for obtaining the repeating unit a7 include those shown below.

[0106] [ka]

[0107] [ka]

[0108] In addition, the component (A) contains, as an ammonium ion constituting an ammonium salt, particularly M in the repeating unit a (repeating units a1 to a7). + It is preferable that the ammonium ion (ammonium cation) is contained in the following general formula (3). [ka] (In the formula, R 101d , R 101e , R 101f , R 101g R is a hydrogen atom, a linear, branched, or cyclic alkyl group having 1 to 14 carbon atoms, a linear, branched, or cyclic alkenyl or alkynyl group having 2 to 12 carbon atoms, or an aromatic group having 4 to 20 carbon atoms, and may have one or more groups selected from an ether group, a carbonyl group, an ester group, a hydroxy group, an amino group, a nitro group, a sulfonyl group, a sulfinyl group, a halogen atom, and a sulfur atom. 101d and R 101e , R 101d and R 101e and R 101f may form a ring together with the nitrogen atom to which they are attached, and when they form a ring, R 101d and R 101e and R 101d and R 101e and R 101f is an alkylene group having 3 to 10 carbon atoms, or forms a heteroaromatic ring having the nitrogen atom in the ring.

[0109] Specific examples of the ammonium ion represented by the above general formula (3) include the following.

[0110] [ka]

[0111]

change

[0112]

change

[0113]

change

[0114]

change

[0115]

change

[0116]

change

[0117]

change

[0118]

change

[0119]

change

[0120]

change

[0121]

change

[0122] [ka]

[0123] [ka]

[0124] [ka]

[0125] [ka]

[0126] As the ammonium ion represented by the above general formula (3), a tertiary or quaternary ammonium ion is particularly preferred.

[0127] (Repeating unit b) The ionic polymer in the present invention preferably contains, in addition to the repeating units a1 to a7, a repeating unit b having an alkoxysilyl group represented by the following general formula (4). [ka] (In the formula, R 20 is a hydrogen atom or a methyl group, X8 is a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group, R 21 R is a single bond, a linear, branched or cyclic alkylene group having 1 to 10 carbon atoms, or a phenylene group, which may contain an oxygen atom or a nitrogen atom. 22 are the same or different alkyl groups having 1 to 4 carbon atoms. b is 0 <b<1.0である。)

[0128] Specific examples of monomers from which the repeating unit b of formula (4) is derived include those shown below.

[0129] [ka]

[0130] (Repeating unit c) In addition to the repeating units a1 to a7 and b, the ionic polymer in component (A) of the bioelectrode composition of the present invention can also be copolymerized with a repeating unit c having a glyme chain in order to improve electrical conductivity. Specific examples of monomers for obtaining the repeating unit c having a glyme chain are shown below. When the bioelectrode of the present invention is a dry electrode, copolymerization of a repeating unit having a glyme chain can promote the movement of ions released from the skin within the dry electrode film, thereby increasing the sensitivity of the dry electrode.

[0131] [ka]

[0132] [ka]

[0133] [ka]

[0134] [ka] R is a hydrogen atom or a methyl group.

[0135] (Repeating unit d) In addition to the repeating units a1 to a7, b, and c described above, the ionic polymer in the component (A) of the bioelectrode composition of the present invention can also be copolymerized with a hydrophilic repeating unit d having a hydroxyl group, a carboxyl group, an ammonium salt, a betaine, an amide group, a pyrrolidone, a lactone ring, a lactam ring, a sultone ring, a sodium salt of sulfonic acid, or a potassium salt of sulfonic acid in order to improve electrical conductivity. Specific examples of monomers for obtaining the hydrophilic repeating unit d are listed below. By copolymerizing repeating units containing these hydrophilic groups, the sensitivity of the ions released from the skin can be increased, and the sensitivity of the dry electrode can be increased.

[0136] [ka]

[0137] [ka] R is a hydrogen atom or a methyl group.

[0138] The ionic polymer in the component (A) in the bioelectrode composition of the present invention can have a repeating unit e that imparts adhesiveness. Specific examples of monomers from which the repeating unit e can be obtained include the following.

[0139] [ka]

[0140] [ka]

[0141] [ka]

[0142] [ka]

[0143] [ka]

[0144] Furthermore, a crosslinkable repeating unit f can be copolymerized. Examples of the crosslinkable repeating unit include a repeating unit having an oxirane ring or an oxetane ring.

[0145] Specific examples of monomers for obtaining the repeating unit f having an oxirane ring or oxetane ring include those shown below.

[0146] [ka]

[0147] [ka] Here, R is a methyl group or a hydrogen atom.

[0148] The ionic polymer in the component (A) of the bioelectrode composition of the present invention can have a silicon-containing repeating unit g in addition to the repeating units selected from the above a1 to a7, b, and c to f. Specifically, the following can be exemplified.

[0149] [ka] n is a number between 0 and 100.

[0150] [ka]

[0151] The ionic polymer in component (A) of the bioelectrode composition of the present invention can have a fluorine-containing repeating unit h in addition to the repeating units selected from the above a1 to a7 and b to g.

[0152] Specific examples of monomers for obtaining the fluorine-containing repeating unit h include the following.

[0153] [ka]

[0154] [ka]

[0155] [ka]

[0156] [ka]

[0157] [ka]

[0158] [ka]

[0159] [ka] Here, R is a hydrogen atom or a methyl group.

[0160] One method for synthesizing the ionic polymer in component (A) (polymer compound before reacting with fine particles) is to heat-polymerize a desired monomer from among the monomers that give the repeating units a1 to a7, b, c, d, e, f, g, and h in an organic solvent with the addition of a radical polymerization initiator to obtain a copolymer polymer compound.

[0161] Examples of the organic solvent used during polymerization include toluene, benzene, tetrahydrofuran, diethyl ether, dioxane, and the like. Examples of the polymerization initiator include 2,2'-azobisisobutyronitrile (AIBN), 2,2'-azobis(2,4-dimethylvaleronitrile), dimethyl 2,2-azobis(2-methylpropionate), benzoyl peroxide, lauroyl peroxide, and the like. The heating temperature is preferably 50 to 80°C, and the reaction time is preferably 2 to 100 hours, more preferably 5 to 20 hours.

[0162] Here, the ratios of the repeating units a1 to a7, b, c, d, e, f, g, h in the ionic polymer in component (A) are as follows: 0 ≦ a1 ≦ 1.0, 0 ≦ a2 ≦ 1.0, 0 ≦ a3 ≦ 1.0, 0 ≦ a4 ≦ 1.0, 0 ≦ a5 ≦ 1.0, 0 ≦ a6 ≦ 1.0, 0 ≦ a7 ≦ 1.0, 0 < a1 + a2 + a3 + a4 + a5 + a6 + a7 ≦ 1.0, 0 ≦ b < 1.0, 0 ≦ c < 1.0, 0 ≦ d < 1.0, 0 ≦ e < 0.9, 0 ≦ f < 0.9, 0 ≦ g < 0.9, 0 ≦ h < 0.9. Preferably, 0 ≦ a1 ≦ 0.9, 0 ≦ a2 ≦ 0.9, 0 ≦ a3 ≦ 0.9, 0 ≦ a4 ≦ 0.9, 0 ≦ a5 ≦ 0.9, 0 ≦ a6 ≦ 0.9, 0 ≦ a7 ≦ 0.9, 0.01 ≦ a1 + a2 + a3 + a4 + a5 + a6 + a7 ≦ 0.99, 0.001 ≦ b ≦ 0.8, 0 ≦ c ≦ 0.8, 0 ≦ d ≦ 0.8, 0 ≦ e < 0.8, 0 ≦ f < 0.8, 0 ≦ g < 0.8, 0 ≦ h < 0.8. More preferably, 0 ≦ a1 ≦ 0.8, 0 ≦ a2 ≦ 0.8, 0 ≦ a3 ≦ 0.8, 0 ≦ a4 ≦ 0.8, 0 ≦ a5 ≦ 0.8, 0 ≦ a6 ≦ 0.8, 0 ≦ a7 ≦ 0.8, 0.02 ≦ a1 + a2 + a3 + a4 + a5 + a6 + a7 ≦ 0.95, 0.01 ≦ b ≦ 0.7, 0 ≦ c ≦ 0.7, 0 ≦ d ≦ 0.5, 0 ≦ e < 0.3, 0 ≦ f < 0.7, 0 ≦ g < 0.7, 0 ≦ h < 0.7.

[0163] For example, a1+a2+a3+a4+a5+a6+a7+b+c+d+e+f+g+h=1 means that in a polymer compound containing repeating units a1, a2, a3, a4, a5, a6, a7, b, c, d, e, f, g, and h, the total amount of repeating units a1, a2, a3, a4, a5, a6, a7, b, c, d, e, f, g, and h is 100 mol % based on the total amount of all repeating units. a1+a2+a3+a4+a5+a6+a7+b+c+d+e+f+g+h<1 means that the total amount of repeating units a1, a2, a3, a4, a5, a6, a7, b, c, d, e, f, g and h is less than 100 mol % based on the total amount of all repeating units, and the polymer has repeating units other than a1, a2, a3, a4, a5, a6, a7, b, c, d, e, f, g and h.

[0164] The molecular weight of the ionic polymer in the component (A) is preferably 500 or more as weight average molecular weight, more preferably 1,000 or more and 1,000,000 or less, and even more preferably 2,000 or more and 500,000 or less. In addition, if the amount of ionic monomer (residual monomer) that is not incorporated into the ionic polymer after polymerization is small, there is no risk of this monomer penetrating into the skin and causing allergies in a biocompatibility test, so it is preferable to reduce the amount of the residual monomer. The amount of the residual monomer is preferably 10 parts by mass or less relative to 100 parts by mass of the total ionic polymer in the component (A). In addition, the ionic polymer may be used alone or in a mixture of two or more types having different molecular weights, dispersities, and polymerized monomers.

[0165] Among the ionic polymers, those having a repeating unit having a structure selected from the group consisting of ammonium salt, lithium salt, sodium salt, potassium salt, and silver salt of N-carbonylfluorosulfonamide, and a repeating unit having an alkoxysilyl group, and having a weight average molecular weight in the range of 1,000 to 1,000,000, are particularly preferred.

[0166] It is more preferable that the repeating unit having a structure selected from the group consisting of ammonium salts, lithium salts, sodium salts, potassium salts, and silver salts of the above-mentioned N-carbonylfluorosulfonamide is a repeating unit a7 represented by the following general formula (5), and that the repeating unit having an alkoxysilyl group is a repeating unit b represented by the following general formula (5). [ka] (In the formula, R 13 are each independently a hydrogen atom or a methyl group, R 14 are each independently a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms which may have either an ester group or an ether group, or both. X7 are each independently a single bond, a phenylene group, a naphthylene group, an ether group, an ester group or an amide group, and M + Rf7 is an ion selected from an ammonium ion, a lithium ion, a sodium ion, a potassium ion, and a silver ion. Rf7 is a fluorine atom or a linear or branched alkyl group having 1 to 4 carbon atoms and has at least one fluorine atom. 20 is a hydrogen atom or a methyl group, and X 8 is a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group, and R 21 R is a single bond, a linear, branched or cyclic alkylene group having 1 to 10 carbon atoms, or a phenylene group, which may contain an oxygen atom or a nitrogen atom. 22 are the same or different alkyl groups having 1 to 4 carbon atoms. a7 is 0 <a7<1.0であり、bは0<b<1.0である。)

[0167] As the particles, silicon material particles, alumina particles, titania particles, zirconia particles, lithium titanate particles, hafnium oxide particles, zinc oxide particles, germanium particles, germanium oxide particles, tin particles, tin oxide particles, antimony oxide particles, strontium oxide particles, tungsten oxide particles, bismuth oxide particles, yttrium oxide particles, ytterbium oxide particles, gadolinium oxide particles, indium oxide particles, molybdenum oxide particles, and scandium oxide particles are preferred, and among these, silicon material particles are particularly preferred. Hereinafter, silicon material particles will be described as an example.

[0168] When the ionic polymer in the component (A) has an alkoxysilyl group, it reacts with the surface of the fine particles and bonds thereto. The reaction method between the repeating unit having the alkoxysilyl group and the silica particles can be, for example, the method described in paragraphs 0065 to 0073 of JP-A-2020-33224 or the method described in WO2015-186596.

[0169] It is preferred that the particles in component (A) are silicon material particles, and that the component (A) is obtained by reacting 100 parts by mass of the silicon material particles with 5 parts by mass or more of the above polymer having an alkoxysilyl group.

[0170] By attaching an ionic polymer to the surface of the silicon material particles, the skin permeability is reduced and the skin irritation is reduced, so that it is possible to better prevent the ionic polymer from passing through the skin and causing allergies.

[0171] Furthermore, by attaching ionic components to the surfaces of the silicon material particles, ionic conductive paths are formed on the surfaces of the silicon material particles, making it possible to increase the sensitivity of the bioelectrode.

[0172] The silicon material particles preferably have a primary particle median diameter (D50) in the range of 2 nm to 50 μm, more preferably in the range of 3 nm to 30 μm, and further preferably in the range of 4 nm to 20 μm. In the present invention, the particle diameter can be determined by a laser light diffraction method.

[0173] There is no particular limitation on the synthesis method of the silicon material particles, and either a dry or wet synthesis method may be used. Silica extracted from rice husks may also be used. Amorphous silica is preferred. Examples of silicon material particles include powders made of silica particles, elemental silicon (Si), silicon monoxide (SiO), silicon carbide (SiC), silicon oxycarbide, silicates, etc. Among these, silicon material powders selected from silica particles, Si particles, SiO particles, SiC particles, or composites thereof are preferred. Silicon particles having silica attached to the surface as described in JP 2015-3839 A may also be used.

[0174] The shape of the silicon material particles may be any of spherical, elliptical, amorphous, and hollow, and may be porous silicon material particles. The inside of the silicon material particles may be metal or resin. Silicon particles whose surfaces are treated with ozone or oxygen plasma to have a silica-like surface may also be used. When porous silicon material particles are treated with an alkoxysilane-containing ionic polymer, the ionic polymer may penetrate and adhere not only to the surface of the silicon material particles but also to the inside of the silicon material particles, but the ionic polymer does not necessarily have to adhere only to the surface of the silicon material particles.

[0175] The composite of the ionic polymer and particles of the present invention is a promising material not only for use in bioelectrodes but also as a negative electrode material for ion batteries. In particular, the combination of the ionic polymer and silicon powder can suppress the deformation of the silicon powder caused by the intercalation of ions entering and leaving when charging and discharging is repeated, by deforming the ionic polymer layer on the surface of the silicon powder.

[0176] In the bioelectrode composition of the present invention, the blending amount of the (A) component is preferably 0.1 to 300 parts by mass, more preferably 1 to 200 parts by mass, per 100 parts by mass of the (B) component described below. The (A) component may be used alone or in combination of two or more kinds.

[0177] In some cases, the alkoxysilyl groups contained in the ionic polymer are not all consumed in the reaction with silica. In this case, the alkoxysilyl groups in the ionic polymer condense with each other. Even in this case, the performance of the bioelectrode is not reduced and the skin irritation is not increased.

[0178] [(B) Adhesive resin] The adhesive resin (B) contained in the bioelectrode composition of the present invention is a component that is compatible with the complex (salt) of the ionic polymer material and particles (A) to prevent the salt from eluting, holds the conductive improver such as metal powder, carbon powder, silicon powder, lithium titanate powder, etc., and exhibits adhesiveness. If the ionic polymer material in the component (A) has adhesiveness, the adhesive resin (B) is not necessarily required. The resin of the component (B) may be any resin other than the above-mentioned component (A), and is preferably either a thermosetting resin or a photocurable resin, or both, and is particularly preferably one or more selected from silicone-based, acrylic-based, and urethane-based resins.

[0179] Examples of adhesive silicone-based resins include those that are cured by addition reaction or radical crosslinking reaction. Examples of the addition reaction cured type include diorganosiloxane having an alkenyl group, RSiO, as described in JP 2015-193803 A. 0.5 and SiO2 units, organohydrogenpolysiloxane having a plurality of SiH groups, platinum catalyst, addition reaction inhibitor, and organic solvent. In addition, as the radical crosslinking reaction curing type, for example, diorganopolysiloxane which may or may not have alkenyl groups, R3SiO 0.5 and those containing an MQ resin having SiO2 units, an organic peroxide, and an organic solvent, where R is a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms.

[0180] It is also possible to use a polysiloxane-resin integrated compound formed by condensing polysiloxane with silanols at the polymer end or side chain with MQ resin. MQ resin contains a lot of silanols, so adding this improves adhesive strength, but since it is not crosslinkable, it is not molecularly bonded to the polysiloxane. By integrating polysiloxane and resin as described above, adhesive strength can be increased.

[0181] In addition, modified siloxanes having a group selected from amino groups, oxirane groups, oxetane groups, polyether groups, hydroxy groups, carboxyl groups, mercapto groups, methacryl groups, acrylic groups, phenol groups, silanol groups, carboxylic anhydride groups, aryl groups, aralkyl groups, amide groups, ester groups, and lactone rings can be added to silicone resins. By adding modified siloxanes, the dispersibility of component (A) in the silicone resin is improved. The modified siloxanes may be modified at one end, both ends, or the side chains of the siloxane.

[0182] The adhesive acrylic resin may be, for example, one having a hydrophilic (meth)acrylic acid ester or a long-chain hydrophobic (meth)acrylic acid ester as a repeating unit, as described in JP 2016-011338 A. In some cases, a (meth)acrylic acid ester having a functional group or a (meth)acrylic acid ester having a siloxane bond may be copolymerized.

[0183] As the adhesive urethane-based resin, for example, one having a urethane bond and a polyether or polyester bond, a polycarbonate bond, or a siloxane bond, as described in JP 2016-065238 A, can be used.

[0184] In addition, in order to prevent the decrease in conductivity due to the detachment of the (A) component from the biocontact layer, in the bioelectrode composition of the present invention, it is preferable that the resin of the (B) component has high compatibility with the above-mentioned (A) component. In addition, in order to prevent the peeling of the biocontact layer from the conductive substrate, it is preferable that the resin of the (B) component has high adhesion to the conductive substrate in the bioelectrode composition of the present invention. In order to make the resin of the (B) component highly compatible with the conductive substrate and salt, it is effective to use a resin with high polarity. Examples of such resins include resins having one or more selected from ether bonds, ester bonds, amide bonds, imide bonds, urethane bonds, thiourethane bonds, and thiol groups, or polyacrylic resins, polyamide resins, polyimide resins, polyurethane resins, and polythiourethane resins. On the other hand, since the biocontact layer contacts the living body, it is easily affected by sweat from the living body. Therefore, in the bioelectrode composition of the present invention, it is preferable that the resin of the (B) component has high water repellency and is difficult to hydrolyze. In order to make the resin of the (B) component highly water repellent and difficult to hydrolyze, it is effective to use a resin containing silicon.

[0185] Silicon-atom-containing polyacrylic resins include polymers having silicone in the main chain and polymers having silicon atoms in the side chain, and both can be used suitably. As the polymer having silicone in the main chain, siloxane or silsesquioxane having a (meth)acrylpropyl group can be used. In this case, the (meth)acryl portion can be polymerized and cured by adding a photoradical generator.

[0186] Suitable examples of polyamide resins containing silicon atoms include polyamide silicone resins described in JP 2011-079946 A and U.S. Patent No. 5,981,680 A. Such polyamide silicone resins can be synthesized by combining, for example, a silicone having amino groups at both ends or a non-silicone compound having amino groups at both ends with a non-silicone having carboxyl groups at both ends or a silicone having carboxyl groups at both ends.

[0187] Alternatively, polyamic acid obtained by reacting a carboxylic anhydride with an amine before cyclization may be used. An epoxy or oxetane crosslinking agent may be used to crosslink the carboxyl groups of the polyamic acid, or the carboxyl groups may be esterified with hydroxyethyl (meth)acrylate to perform photoradical crosslinking of the (meth)acrylate portion.

[0188] As the polyimide resin containing silicon atoms, for example, the polyimide silicone resin described in JP-A-2002-332305 can be suitably used. Polyimide resins have a very high viscosity, but the viscosity can be reduced by blending a (meth)acrylic monomer as a solvent and a crosslinking agent.

[0189] Examples of polyurethane resins containing silicon atoms include polyurethane silicone resins. In such polyurethane silicone resins, crosslinking by urethane bonds can be performed by blending and heating a compound having isocyanate groups at both ends and a compound having hydroxyl groups at the ends. In this case, it is necessary to contain silicon atoms (siloxane bonds) in either or both of the compound having isocyanate groups at both ends and the compound having hydroxyl groups at the ends. Alternatively, as described in JP 2005-320418 A, a urethane (meth)acrylate monomer can be blended with polysiloxane to perform photocrosslinking. In addition, a polymer having both siloxane bonds and urethane bonds and a (meth)acrylate group at the end can also be photocrosslinked. In particular, the silicone chain attached to the side chain and the polyurethane main chain described in JP 2018-123304 A and JP 2019-70109 A are preferred because they have high strength and high elasticity.

[0190] The polythiourethane resin containing silicon atoms can be obtained by reacting a compound having a thiol group with a compound having an isocyanate group, and any one of them may contain a silicon atom. In addition, if the compound has a (meth)acrylate group at the end, it can be photocured.

[0191] In the silicone resin, the above-mentioned diorganosiloxane having an alkenyl group, RSiO 0.5 In addition to MQ resins having SiO2 units and organohydrogenpolysiloxanes having multiple SiH groups, the compatibility with the above-mentioned salts is improved by adding modified siloxanes having groups selected from amino groups, oxirane groups, oxetane groups, polyether groups, hydroxyl groups, carboxyl groups, mercapto groups, methacryl groups, acrylic groups, phenol groups, silanol groups, carboxylic anhydride groups, aryl groups, aralkyl groups, amide groups, ester groups, and lactone rings.

[0192] Diorganosiloxanes having alkenyl groups and organohydrogenpolysiloxanes having multiple SiH groups can be crosslinked by an addition reaction in the presence of a platinum catalyst.

[0193] Examples of platinum catalysts include platinum catalysts such as chloroplatinic acid, alcohol solutions of chloroplatinic acid, reaction products of chloroplatinic acid and alcohol, reaction products of chloroplatinic acid and olefin compounds, reaction products of chloroplatinic acid and vinyl group-containing siloxane, platinum-olefin complexes, platinum-vinyl group-containing siloxane complexes, platinum group metal catalysts such as rhodium complexes and ruthenium complexes, etc. Furthermore, these catalysts may be used in the form of a solution or dispersion in an alcohol-based, hydrocarbon-based, or siloxane-based solvent.

[0194] The amount of the platinum catalyst added is preferably within a range of 5 to 2,000 ppm, and particularly preferably 10 to 500 ppm, per 100 parts by mass of the resin of component (B).

[0195] In the bioelectrode composition of the present invention, the blending amount of the (B) component is preferably 0 to 2000 parts by mass, more preferably 10 to 1000 parts by mass, per 100 parts by mass of the complex (A) of an ionic polymer material and particles. In addition, each of the (B) components may be used alone or in combination of two or more kinds.

[0196] When an addition-curing silicone resin is used, an addition reaction inhibitor may be added as a quencher to prevent the platinum catalyst from acting in the solution and in a low-temperature environment before heat curing after coating formation. Specific examples include 3-methyl-1-butyn-3-ol, 3-methyl-1-pentyn-3-ol, 3,5-dimethyl-1-hexyn-3-ol, 1-ethynylcyclohexanol, 3-methyl-3-trimethylsiloxy-1-butyne, 3-methyl-3-trimethylsiloxy-1-pentyne, 3,5-dimethyl-3-trimethylsiloxy-1-hexyne, 1-ethynyl-1-trimethylsiloxycyclohexane, bis(2,2-dimethyl-3-butynoxy)dimethylsilane, 1,3,5,7-tetramethyl-1,3,5,7-tetravinylcyclotetrasiloxane, and 1,1,3,3-tetramethyl-1,3-divinyldisiloxane.

[0197] The amount of the addition reaction inhibitor added is preferably within the range of 0 to 10 parts by mass, and particularly preferably 0.05 to 3 parts by mass, per 100 parts by mass of the resin of component (B).

[0198] In order to crosslink the radically crosslinkable groups of the component (B) of the present invention, it is effective to add a radical generator. Radical generators include photoradical generators and thermal radical generators.

[0199] Examples of photoradical generators include acetophenone, 4,4'-dimethoxybenzyl, benzil, benzoin, benzophenone, 2-benzoylbenzoic acid, 4,4'-bis(dimethylamino)benzophenone, 4,4'-bis(diethylamino)benzophenone, benzoin methyl ether, benzoin ethyl ether, benzoin isopropyl ether, benzoin butyl ether, benzoin isobutyl ether, 4-benzoylbenzoic acid, 2,2'-bis(2-chlorophenyl)-4,4',5,5'-tetraphenyl-1,2'-biimidazole, 2-benzoylbenzoic acid methyl ester, 2-(1,3-benzodioxol-5-yl)-4,6-bis(trichloromethyl)-1,3,5-triazine, 2-benzoylbenzoic acid methyl ester ... Examples of suitable acetophenones include 2-(dimethylamino)-4'-morpholinobutyrophenone, 4,4'-dichlorobenzophenone, 2,2-diethoxyacetophenone, 2,2-dimethoxy-2-phenylacetophenone, 2,4-diethylthioxanthen-9-one, diphenyl(2,4,6-trimethylbenzoyl)phosphine oxide (BAPO), 1,4-dibenzoylbenzene, 2-ethylanthraquinone, 1-hydroxycyclohexyl phenyl ketone, 2-hydroxy-2-methylpropiophenone, 2-hydroxy-4'-(2-hydroxyethoxy)-2-methylpropiophenone, 2-isonitrosopropiophenone, and 2-phenyl-2-(p-toluenesulfonyloxy)acetophenone.

[0200] It can also be cured by adding a thermally decomposable radical generator. Examples of thermal radical generators include 2,2'-azobis(isobutyronitrile), 2,2'-azobis(2,4-dimethylvaleronitrile), 2,2'-azobis(2-methylbutyronitrile), 2,2'-azobis(methylpropionamidine) hydrochloride, 2,2'-azobis[2-(2-imidazolin-2-yl)propane]hydrochloride, 2,2'-azobis(4-methoxy-2,4-dimethylvaleronitrile), 2,2'-azobis(cyclohexane-1-carbonitrile), 1[(1-cyano-1-methylethyl)azo]formamide, 2,2'-azobis[2-methyl-N-(2-hydroxyethyl )propionamide], 2,2'-azobis[N-(2-propenyl)-2-methylpropionamide], 2,2'-azobis(N-butyl-2-methylpropionamide), dimethyl-2,2'-azobis(isobutyrate), 4,4'-azobis(4-cyanopentanoic acid), dimethyl-2,2'-azobis(2-methylpropionate), benzoyl peroxide, tert-butyl hydroperoxide, cumene hydroperoxide, di-tert-butyl peroxide, di-tert-amyl peroxide, di-n-butyl peroxide, dicumyl peroxide, and the like.

[0201] The amount of the radical generator added is preferably within a range of 0.1 to 50 parts by mass per 100 parts by mass of the resin of the component (B).

[0202] Among these, the resin of component (B) is more preferably one containing a diorganosiloxane having an alkenyl group and an organohydrogenpolysiloxane having a SiH group, and further preferably R x SiO (4-x) / 2 Particularly preferred are those containing a silicone resin having a unit (R is a substituted or unsubstituted monovalent hydrocarbon group having 1 to 10 carbon atoms, and x is in the range of 2.5 to 3.5) and a SiO2 unit.

[0203] As described later, the biocontact layer is a cured product of the bioelectrode composition. By curing, the adhesion of the biocontact layer to both the skin and the conductive substrate is improved. The curing method is not particularly limited, and a general method can be used, for example, heat and / or light, or a crosslinking reaction using an acid or base catalyst. The crosslinking reaction can be carried out by appropriately selecting a method described in, for example, Crosslinking Reaction Handbook, Nakayama Hiroharu, Maruzen Publishing (2013), Chapter 2, p. 51 to p. 371.

[0204] [(C) Blended ionic polymer] In addition to the component (A), an ionic polymer (blended ionic polymer) can be added to the bioelectrode composition of the present invention. The repeating units of the blended ionic polymer can be those described in the ionic polymer in the component (A), particularly those represented by the general formula (2). The amount of the blended ionic polymer added is preferably in the range of 0.1 to 100 parts by mass per 100 parts by mass of the resin in the component (B).

[0205] [(D) Conductive powder] [Metal powder] In order to enhance electronic conductivity, the bioelectrode composition of the present invention may contain, as component (D), a metal powder selected from gold, silver, platinum, copper, tin, titanium, nickel, aluminum, tungsten, molybdenum, ruthenium, chromium, and indium. The amount of metal powder added is preferably within the range of 1 to 50 parts by mass per 100 parts by mass of the resin of component (B).

[0206] As the type of metal powder, gold, silver, and platinum are preferred from the viewpoint of electrical conductivity, and silver, copper, tin, titanium, nickel, aluminum, tungsten, molybdenum, ruthenium, and chromium are preferred from the viewpoint of cost. From the viewpoint of biocompatibility, noble metals are preferred, and from these viewpoints overall, silver is the most preferred.

[0207] The shape of the metal powder can be spherical, disk-like, flake-like, or needle-like, but the addition of flake-like powder is the most conductive and is preferred. The size of the metal powder is 100 μm or less, and the tap density is 5 g / cm. 3 Below, the specific surface area is 0.5m 2 Flakes with a relatively low density and large specific surface area of ​​100 / g or more are preferred.

[0208] [Carbon powder] A carbon material (carbon powder) can be added as a conductivity improver. Examples of the carbon material include carbon black, graphite, carbon nanotubes, and carbon fibers. The carbon nanotubes may be either single-walled or multi-walled, and the surface may be modified with an organic group. The amount of the carbon material added is preferably in the range of 1 to 50 parts by mass per 100 parts by mass of the resin of component (B).

[0209] [Silicon powder] Silicon powder can be added to the bioelectrode composition of the present invention in order to increase the sensitivity of ion reception. Examples of silicon powder include powders made of silicon, silicon monoxide, and silicon carbide. The particle size of the powder is preferably smaller than 100 μm, and more preferably 1 μm or less. Since finer particles have a larger surface area, they can receive more ions, resulting in a highly sensitive bioelectrode. The amount of silicon powder added is preferably in the range of 1 to 50 parts by mass per 100 parts by mass of the resin of component (B).

[0210] [Lithium titanate powder] Lithium titanate powder can be added to the bioelectrode composition of the present invention in order to increase the sensitivity of ion reception. Lithium titanate powder includes Li2TiO3, LiTiO2, and Li4Ti5O with a spinel structure. 12The molecular formula of the lithium titanate powder is as follows, and a spinel structure is preferable. Lithium titanate particles composited with carbon can also be used. The particle size of the powder is preferably smaller than 100 μm, more preferably 1 μm or less. Since finer particles have a larger surface area, they can receive more ions, resulting in a highly sensitive bioelectrode. These may be composite powders with carbon. The amount of lithium titanate powder added is preferably in the range of 1 to 50 parts by mass per 100 parts by mass of the resin of component (B).

[0211] [(E) Organic solvent] In addition, an organic solvent can be added as component (E) to the bioelectrode composition of the present invention. Specific examples of the organic solvent include toluene, xylene, cumene, 1,2,3-trimethylbenzene, 1,2,4-trimethylbenzene, 1,3,5-trimethylbenzene, styrene, α-methylstyrene, butylbenzene, sec-butylbenzene, isobutylbenzene, cymene, diethylbenzene, 2-ethyl-p-xylene, 2-propyltoluene, 3-propyltoluene, 4-propyltoluene, 1,2,3,5-tetramethyltoluene, 1,2,4,5-tetramethyltoluene, tetrahydrofuran, and the like. naphthalene, 4-phenyl-1-butene, tert-amylbenzene, amylbenzene, 2-tert-butyltoluene, 3-tert-butyltoluene, 4-tert-butyltoluene, 5-isopropyl-m-xylene, 3-methylethylbenzene, tert-butyl-3-ethylbenzene, 4-tert-butyl-o-xylene, 5-tert-butyl-m-xylene, tert-butyl-p-xylene, 1,2-diisopropylbenzene, 1,3-diisopropylbenzene, 1,4-diisopropylbenzene, Aromatic hydrocarbon solvents such as isopropylbenzene, dipropylbenzene, pentamethylbenzene, hexamethylbenzene, hexylbenzene, and 1,3,5-triethylbenzene, n-heptane, isoheptane, 3-methylhexane, 2,3-dimethylpentane, 3-ethylpentane, 1,6-heptadiene, 5-methyl-1-hexyne, norbornane, norbornene, dicyclopentadiene, 1-methyl-1,4-cyclohexadiene, 1-heptyne, 2-heptyne, cycloheptane, and cyclohexene. butene, 1,3-dimethylcyclopentane, ethylcyclopentane, methylcyclohexane, 1-methyl-1-cyclohexene, 3-methyl-1-cyclohexene, methylenecyclohexane, 4-methyl-1-cyclohexene, 2-methyl-1-hexene, 2-methyl-2-hexene, 1-heptene, 2-heptene, 3-heptene, n-octane, 2,2-dimethylhexane, 2,3-dimethylhexane, 2,4-dimethylhexane, 2,5-dimethylhexane, 3,3-dimethylhexane, 3,4-Dimethylhexane, 3-ethyl-2-methylpentane, 3-ethyl-3-methylpentane, 2-methylheptane, 3-methylheptane, 4-methylheptane, 2,2,3-trimethylpentane, 2,2,4-trimethylpentane, cyclooctane, cyclooctene, 1,2-dimethylcyclohexane, 1,3-dimethylcyclohexane, 1,4-dimethylcyclohexane, ethylcyclohexane, vinylcyclohexane, isopropylcyclopentane, 2,2-dimethyl-3-hexene, 2,4-dimethyl-1-hexene, 2,5-dimethyl-1- Hexene, 2,5-dimethyl-2-hexene, 3,3-dimethyl-1-hexene, 3,4-dimethyl-1-hexene, 4,4-dimethyl-1-hexene, 2-ethyl-1-hexene, 2-methyl-1-heptene, 1-octene, 2-octene, 3-octene, 4-octene, 1,7-octadiene, 1-octyne, 2-octyne, 3-octyne, 4-octyne, n-nonane, 2,3-dimethylheptane, 2,4-dimethylheptane, 2,5-dimethylheptane, 3,3-dimethylheptane, 3,4-dimethylheptane, 3,5-dimethylheptane, 4-ethylhexene, ethylheptane, 2-methyloctane, 3-methyloctane, 4-methyloctane, 2,2,4,4-tetramethylpentane, 2,2,4-trimethylhexane, 2,2,5-trimethylhexane, 2,2-dimethyl-3-heptene, 2,3-dimethyl-3-heptene, 2,4-dimethyl-1-heptene, 2,6-dimethyl-1-heptene, 2,6-dimethyl-3-heptene, 3,5-dimethyl-3-heptene, 2,4,4-trimethyl-1-hexene, 3,5,5-trimethyl-1-hexene, 1-ethyl-2-methylcyclohexane, 1-ethyl-3 -Methylcyclohexane, 1-ethyl-4-methylcyclohexane, propylcyclohexane, isopropylcyclohexane, 1,1,3-trimethylcyclohexane, 1,1,4-trimethylcyclohexane, 1,2,3-trimethylcyclohexane, 1,2,4-trimethylcyclohexane, 1,3,5-trimethylcyclohexane, allylcyclohexane, hydrindane, 1,8-nonadiene, 1-nonyne, 2-nonyne, 3-nonyne, 4-nonyne, 1-nonene, 2-nonene, 3-nonene, 4-nonene, n-decane, 3,3-dimethyloctane, 3,5-dimethyloctane, 4,4-dimethyloctane, 3-ethyl-3-methylheptane, 2-methylnonane, 3-methylnonane, 4-methylnonane, tert-butylcyclohexane, butylcyclohexane, isobutylcyclohexane, 4-isopropyl-1-methylcyclohexane, pentylcyclopentane, 1,1,3,5-tetramethylcyclohexane, cyclododecane, 1-decene, 2-decene, 3-decene, 4-decene, 5-decene, 1,9-decadiene, decahydronaphthalene, 1-decene, 2-decene, 3-decene, 4-decene, 5-decene, 1, 5,9-Decatriene, 2,6-dimethyl-2,4,6-octatriene, limonene, myrcene, 1,2,3,4,5-pentamethylcyclopentadiene, α-phellandrene, pinene, terpinene, tetrahydrodicyclopentadiene, 5,6-dihydrodicyclopentadiene, 1,4-decadiyne, 1,5-decadiyne, 1,9-decadiyne, 2,8-decadiyne, 4,6-decadiyne, n-undecane, amylcyclohexane, 1-undecene, 1,10-undecadiene, 1-undecyne, 3-undecyne, 5-undecyne, tricyclo[6.2.1.0, 2,7]Undec-4-ene, n-dodecane, 2-methylundecane, 3-methylundecane, 4-methylundecane, 5-methylundecane, 2,2,4,6,6-pentamethylheptane, 1,3-dimethyladamantane, 1-ethyladamantane, 1,5,9-cyclododecatriene, 1,2,4-trivinylcyclohexane, aliphatic hydrocarbon solvents such as isoparaffin, cyclohexanone, cyclopentanone, 2-octanone, 2-nonanone, 2-heptanone, 3-heptanone, 4-heptanone, 2-hexanone, 3-hexanone, diisobutyl ketone , methylcyclohexanone, methyl n-pentyl ketone and other ketone-based solvents, 3-methoxybutanol, 3-methyl-3-methoxybutanol, 1-methoxy-2-propanol, 1-ethoxy-2-propanol and other alcohol-based solvents, propylene glycol monomethyl ether, ethylene glycol monomethyl ether, propylene glycol monoethyl ether, ethylene glycol monoethyl ether, propylene glycol dimethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol Examples of the solvent include ether solvents such as glycol monopropyl ether, diethylene glycol monobutyl ether, diethylene glycol monopentyl ether, diethylene glycol monoheptyl ether, diethylene glycol diethyl ether, diethylene glycol dipropyl ether, diethylene glycol dibutyl ether, diisopropyl ether, diisobutyl ether, diisopentyl ether, di-n-pentyl ether, methylcyclopentyl ether, methylcyclohexyl ether, di-n-butyl ether, di-sec-butyl ether, di-sec-pentyl ether, di-tert-amyl ether, di-n-hexyl ether, and anisole; ester solvents such as propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, ethyl lactate, ethyl pyruvate, butyl acetate, methyl 3-methoxypropionate, ethyl 3-ethoxypropionate, tert-butyl acetate, tert-butyl propionate, and propylene glycol mono-tert-butyl ether acetate; lactone solvents such as γ-butyrolactone; and water.

[0212] The amount of the organic solvent added is preferably within a range of 10 to 50,000 parts by mass per 100 parts by mass of the resin of the component (B).

[0213] [(F) Other additives] The bioelectrode composition of the present invention can be mixed with a platinum catalyst, an addition reaction control agent, a radical generator, a crosslinking agent, a crosslinking catalyst, an ionic additive, and further with silica particles, polyether silicone, and polyglycerin silicone, as well as the platinum catalyst, an addition reaction control agent, and a radical generator, as described in the (B) component section. Silica particles have a hydrophilic surface and are compatible with hydrophilic ionic polymers, polyether silicones, and polyglycerin silicones, and can improve the dispersibility of ionic polymers, polyether silicones, and polyglycerin silicones in hydrophobic silicone adhesives. Silica particles can be used preferably in either dry or wet processes.

[0214] [Crosslinking agent] An epoxy-based crosslinking agent can be added to the bioelectrode composition of the present invention. In this case, the crosslinking agent is a compound having multiple epoxy groups or oxetane groups in one molecule. The amount of the crosslinking agent to be added is 1 to 30 parts by mass per 100 parts by mass of the resin of component (B).

[0215] [Crosslinking catalyst] A catalyst for crosslinking epoxy groups or oxetane groups can also be added to the bioelectrode composition of the present invention. In this case, the catalysts described in paragraphs 0027 to 0029 of JP-A-2019-503406 can be used. The amount of the catalyst added is 0.01 to 10 parts by mass per 100 parts by mass of the resin of component (B).

[0216] [Ionic additives] The bioelectrode composition of the present invention can be added with an ionic additive to increase ionic conductivity. In consideration of biocompatibility, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, saccharin sodium salt, acesulfame potassium, sodium carboxylate, potassium carboxylate, calcium carboxylate, sodium sulfonate, potassium sulfonate, calcium sulfonate, sodium phosphate, potassium phosphate, calcium phosphate, magnesium phosphate, betaine, and salts disclosed in JP-A-2018-44147, JP-A-2018-59050, JP-A-2018-59052, and JP-A-2018-130534 can be mentioned.

[0217] [Silicone compounds having polyglycerin structure] In the bioelectrode composition of the present invention, a silicone compound having a polyglycerin structure can be added in order to improve the moisture retention of the membrane and improve the sensitivity and ion conductivity of ions released from the skin. The amount of the silicone compound having a polyglycerin structure is preferably 0.01 to 100 parts by mass, more preferably 0.5 to 60 parts by mass, per 100 parts by mass of the total of the (A) component and the (B) component. The silicone compound having a polyglycerin structure may be used alone or in a mixture of two or more types.

[0218] The silicone compound having a polyglycerin structure is preferably one represented by the following general formulas (4)' and (5)'.

[0219] [ka] (In formulas (4)' and (5)', R 1 are each independent and may be the same or different, each independently represent a hydrogen atom, a linear or branched alkyl group having 1 to 50 carbon atoms, or a phenyl group, each independently represent a silicone chain represented by the general formula (6)' ... 2R′ is a group having a polyglycerin group structure represented by formula (4)′-1 or formula (4)′-2, 3 ' are each independent and may be the same or different, 1 ' group or the R 2 ' group, R 4 ' are each independent and may be the same or different, 1 ' group, the R 2 R is a ' group or an oxygen atom. 4 If ' is an oxygen atom, then two R 4 The a' groups may be bonded to form a single ether group to form a ring together with the silicon atom. a' may be the same or different and is 0 to 100, b' is 0 to 100, and a'+b' is 0 to 200. However, when b' is 0, R 3 At least one of the R 2 In formulae (4)'-1, (4)'-2 and (5)', R 5 ' is an alkylene group having 2 to 10 carbon atoms or an aralkylene group having 7 to 10 carbon atoms; R 6 ', R 7 ' is an alkylene group having 2 to 6 carbon atoms, and R 7 ' may be an ether bond, c' is 0 to 20, and d' is 1 to 20.

[0220] Examples of such silicone compounds having a polyglycerin structure include the following.

[0221] [ka]

[0222] [ka]

[0223] [ka]

[0224] [ka]

[0225] [ka]

[0226] [ka]

[0227] [ka]

[0228] [ka]

[0229] [ka]

[0230] [ka] (wherein a', b', c' and d' are as defined above).

[0231] A bioelectrode composition containing a silicone compound having such a polyglycerin structure can exhibit better moisturizing properties, and as a result, can form a biocontact layer that can exhibit better sensitivity to ions released from the skin.

[0232] As described above, the bioelectrode composition of the present invention can efficiently transmit electrical signals from the skin to the device (i.e., has excellent electrical conductivity), is not likely to cause allergies even when worn on the skin for a long period of time (i.e., has excellent biocompatibility), is lightweight, can be manufactured at low cost, and can form a biocontact layer for a bioelectrode that does not significantly decrease in electrical conductivity even when wet or dried. In addition, the electrical conductivity can be further improved by adding a conductive powder (carbon powder, metal powder), and a bioelectrode with particularly high adhesive strength and high elasticity can be manufactured by combining it with a resin having adhesiveness and elasticity. Furthermore, the elasticity and adhesiveness to the skin can be improved by additives, and the elasticity and adhesiveness can be adjusted by appropriately adjusting the composition of the resin and the thickness of the biocontact layer.

[0233] <Bioelectrode> The present invention also provides a bioelectrode having a conductive substrate and a biocontact layer formed on the conductive substrate, the bioelectrode being a cured product of the bioelectrode composition of the present invention described above.

[0234] The bioelectrode of the present invention will be described in detail below with reference to the drawings, but the present invention is not limited thereto.

[0235] FIG. 1 is a schematic cross-sectional view showing an example of the bioelectrode of the present invention. The bioelectrode 1 of FIG. 1 has a conductive substrate 2 and a biocontact layer 3 formed on the conductive substrate 2. The biocontact layer 3 is made of a cured product of the bioelectrode composition of the present invention. The ionic complex 4 constituting the biocontact layer 3 is a complex of the ionic polymer material and particles (for example, silicon material particles modified with the ionic polymer). The biocontact layer 3 can further contain an adhesive resin 6 other than the ionic complex 4 and a blended ionic polymer 5. Hereinafter, with reference to FIGS. 1 and 2, a case where the biocontact layer 3 is a layer in which the ionic complex 4 and the blended ionic polymer 5 are dispersed in the adhesive resin 6 will be described, but the bioelectrode of the present invention is not limited to this embodiment.

[0236] When using such a bioelectrode 1 of Fig. 1, as shown in Fig. 2, the biocontact layer 3 (i.e., a layer in which the ionic complex 4 and the blended ionic polymer 5 are dispersed in the adhesive resin 6) is brought into contact with a living body 7, and an electrical signal is extracted from the living body 7 by the ionic complex 4 and the blended ionic polymer 5, and the electrical signal is conducted to a sensor device or the like (not shown) via the conductive substrate 2. In this way, the bioelectrode of the present invention can achieve both electrical conductivity and biocompatibility by the above-mentioned ionic complex 4, and has adhesiveness so that the contact area with the skin is constant, and electrical signals from the skin can be obtained stably and with high sensitivity.

[0237] Each of the constituent materials of the bioelectrode of the present invention will be described in more detail below.

[0238] [Conductive base material] The bioelectrode of the present invention has a conductive substrate. This conductive substrate is usually electrically connected to a sensor device or the like, and conducts an electrical signal extracted from a living body via a living body contact layer to the sensor device or the like.

[0239] The conductive substrate is not particularly limited as long as it is conductive, but it is preferable that the conductive substrate contains at least one material selected from the group consisting of gold, silver, silver chloride, platinum, aluminum, magnesium, tin, tungsten, iron, copper, nickel, stainless steel, chromium, titanium, carbon, and conductive polymers.

[0240] The conductive substrate is not particularly limited and may be a hard conductive substrate, a flexible conductive film, a fabric coated with a conductive paste, or a fabric with a conductive polymer kneaded in. The conductive substrate may be flat or uneven, or may be a mesh of woven metal wires, and may be appropriately selected depending on the application of the bioelectrode.

[0241] [Bio-contact layer] The bioelectrode of the present invention has a biocontact layer formed on a conductive substrate. This biocontact layer is the part that actually comes into contact with the living body when the bioelectrode is used, and has electrical conductivity and adhesiveness. The biocontact layer is a cured product of the bioelectrode composition of the present invention described above, that is, an adhesive resin layer made of a cured product of a composition containing the above-mentioned component (A) and, if necessary, components (B), (C), (D), (E), and (F).

[0242] The adhesive strength of the living body contact layer is preferably in the range of 0.5 N / 25 mm to 20 N / 25 mm. The adhesive strength is generally measured by the method shown in JIS Z 0237. A metal substrate such as SUS (stainless steel) or a PET (polyethylene terephthalate) substrate can be used as the substrate, but human skin can also be used for measurement. The surface energy of human skin is lower than that of metals and various plastics, and is close to that of Teflon (registered trademark), making it difficult to adhere to the skin.

[0243] The thickness of the biocontact layer of the bioelectrode is preferably 1 μm to 5 mm, more preferably 2 μm to 3 mm. The thinner the biocontact layer, the weaker the adhesive strength, but the more flexible it is, the lighter it is, and the better it fits to the skin. The thickness of the biocontact layer can be selected based on the balance between adhesiveness and texture on the skin.

[0244] In addition, in the bioelectrode of the present invention, similar to conventional bioelectrodes (for example, the bioelectrode described in JP 2004-033468 A), a separate adhesive film may be provided on the biocontact layer to prevent the bioelectrode from peeling off from the living body during use. When providing a separate adhesive film, it is sufficient to form the adhesive film using an adhesive film material such as an acrylic type, a urethane type, or a silicone type. In particular, the silicone type has high oxygen permeability, so that the skin can breathe while it is attached, and has high water repellency, so that the adhesiveness is less likely to decrease due to sweat, and further, is less irritating to the skin, so it is preferable. In addition, in the bioelectrode of the present invention, as described above, peeling off from the living body can be prevented by adding an adhesive imparting agent to the bioelectrode composition or using a resin that has good adhesiveness to the living body, so that the above-mentioned separate adhesive film is not necessarily required.

[0245] When the bioelectrode of the present invention is used as a wearable device, the wiring between the bioelectrode and the sensor device and other components are not particularly limited, and for example, those described in JP 2004-033468 A can be applied.

[0246] As described above, the bioelectrode of the present invention has a biocontact layer formed of the cured product of the bioelectrode composition of the present invention, so that the bioelectrode can efficiently transmit electrical signals from the skin to the device (i.e., has excellent electrical conductivity), is not likely to cause allergies even when worn on the skin for a long period of time (i.e., has excellent biocompatibility), is lightweight, can be manufactured at low cost, and does not significantly decrease in electrical conductivity even when wet or dried. In addition, the electrical conductivity can be further improved by adding a conductive powder, and a bioelectrode with particularly high adhesive strength and high elasticity can be manufactured by combining it with a resin having adhesiveness and elasticity. Furthermore, the elasticity and adhesiveness to the skin can be improved by additives, and the elasticity and adhesiveness can be adjusted by appropriately adjusting the composition of the resin and the thickness of the biocontact layer. Therefore, such a bioelectrode of the present invention is particularly suitable as a bioelectrode used in a medical wearable device.

[0247] <Manufacturing method of bioelectrodes> The present invention also provides a method for manufacturing a bioelectrode having a conductive substrate and a biocontact layer formed on the conductive substrate, in which the bioelectrode composition of the present invention described above is applied to the conductive substrate and cured to form the biocontact layer.

[0248] The conductive substrate and the like used in the method for producing a bioelectrode of the present invention may be the same as those described above.

[0249] The method for applying the bioelectrode composition onto the conductive substrate is not particularly limited, but suitable methods include, for example, dip coating, spray coating, spin coating, roll coating, flow coating, doctor coating, screen printing, flexographic printing, gravure printing, and inkjet printing.

[0250] The resin curing method is not particularly limited and may be appropriately selected depending on the components (A) and (B) used in the bioelectrode composition, but it is preferable to cure the resin by, for example, heat or light, or both. In addition, a catalyst that generates an acid or base may be added to the bioelectrode composition to cause a crosslinking reaction and cure the resin.

[0251] The temperature for heating is not particularly limited and may be appropriately selected depending on the components (A) and (B) used in the bioelectrode composition, but is preferably about 50 to 250°C, for example.

[0252] In addition, when heating and light irradiation are combined, heating and light irradiation may be performed simultaneously, or heating may be performed after light irradiation, or light irradiation may be performed after heating. In addition, air drying may be performed before heating after coating in order to evaporate the solvent.

[0253] After the film has hardened, applying water droplets or spraying water vapor or mist on the surface improves its compatibility with the skin, allowing for quick biosignals to be obtained. Water mixed with alcohol can also be used to reduce the size of the vapor or mist droplets. The film surface can also be wetted by contacting it with absorbent cotton or cloth soaked in water.

[0254] The water that wets the surface of the cured film may contain a salt, and the water-soluble salt that is mixed with the water is selected from sodium salts, potassium salts, calcium salts, magnesium salts, and betaines.

[0255] Specifically, the water-soluble salt may be a salt selected from sodium chloride, potassium chloride, calcium chloride, magnesium chloride, saccharin sodium salt, acesulfame potassium, sodium carboxylate, potassium carboxylate, calcium carboxylate, sodium sulfonate, potassium sulfonate, calcium sulfonate, sodium phosphate, potassium phosphate, calcium phosphate, magnesium phosphate, and betaine. Note that the above-mentioned components (A) and (C) are not included in the water-soluble salt.

[0256] More specifically, in addition to the above, sodium acetate, sodium propionate, sodium pivalate, sodium glycolate, sodium butyrate, sodium valerate, sodium caproate, sodium enanthate, sodium caprylate, sodium pelargonate, sodium caprate, sodium undecylate, sodium laurate, sodium tridecylate, sodium myristate, sodium pentadecylate, sodium palmitate, sodium margarate, sodium stearate, sodium benzoate, disodium adipate, disodium maleate, disodium phthalate, sodium 2-hydroxybutyrate, sodium 3-hydroxybutyrate, sodium 2-oxobutyrate, sodium gluconate, methane Examples of betaines include sodium sulfonate, sodium 1-nonanesulfonate, sodium 1-decanesulfonate, sodium 1-dodecanesulfonate, sodium 1-undecanesulfonate, sodium cocoyl ethionate, sodium lauroyl methyl alanine, sodium cocoyl methyl taurate, sodium cocoyl glutamate, sodium cocoyl sarcosine, sodium lauroyl methyl taurate, laumidopropyl betaine, potassium isobutyrate, potassium propionate, potassium pivalate, potassium glycolate, potassium gluconate, potassium methanesulfonate, calcium stearate, calcium glycolate, calcium gluconate, calcium 3-methyl-2-oxobutyrate, and calcium methanesulfonate. Betaine is a general term for intramolecular salts, specifically a compound in which three methyl groups are added to the amino group of an amino acid, and more specifically, trimethylglycine, carnitine, and proline betaine can be mentioned.

[0257] The water that wets the surface of the cured film may further contain a monohydric alcohol or polyhydric alcohol having 1 to 4 carbon atoms. The alcohol is preferably selected from ethanol, isopropyl alcohol, ethylene glycol, diethylene glycol, triethylene glycol, glycerin, polyethylene glycol, polypropylene glycol, polyglycerin, diglycerin, or a silicone compound having a polyglycerin structure, and it is more preferable that the silicone compound having a polyglycerin structure is one represented by the above general formula (4)' or (5)'.

[0258] The pretreatment method using a water-soluble salt-containing aqueous solution can wet the bioelectrode membrane after hardening by spraying, dispensing water droplets, etc. It can also be wetted in a high temperature and high humidity state such as a sauna. After wetting, in order to prevent drying, a protective film can be further laminated on the permeation layer to cover it. Since the protective film needs to be peeled off just before applying it to the skin, it can be coated with a release agent or a peelable Teflon (registered trademark) film can be used. For long-term storage, the dry electrode covered with the release film is preferably sealed in a bag covered with aluminum or the like. In order to prevent drying in the aluminum-covered bag, it is preferable to seal moisture in it.

[0259] Before attaching the bioelectrode of the present invention to the skin, the skin side can be moistened with water, alcohol, etc., or the skin can be wiped with a cloth or absorbent cotton containing water, alcohol, etc. The above-mentioned salt can also be contained in the water or alcohol.

[0260] As described above, the manufacturing method of the bioelectrode of the present invention makes it possible to easily manufacture, at low cost, the bioelectrode of the present invention which has excellent conductivity and biocompatibility, is lightweight, and whose conductivity does not decrease significantly whether it is wetted with water or dried. EXAMPLES

[0261] The present invention will be specifically described below using examples and comparative examples, but the present invention is not limited to these. In the following, "Me" represents a methyl group and "Vi" represents a vinyl group.

[0262] (ionic polymer) Ionic polymers 1 to 14, which were blended as ionic materials (conductive materials) in the bioelectrode composition solution, were synthesized as follows. A 30% by mass solution of each monomer in cyclopentanone was placed in a reaction vessel and mixed, and the reaction vessel was cooled to -70°C under a nitrogen atmosphere, and degassed under reduced pressure and nitrogen blowing were repeated three times. After heating to room temperature, 0.02 mol of azobisisobutyronitrile (AIBN) was added as a polymerization initiator per mol of the total monomers, and the mixture was heated to 60°C and reacted for 15 hours. The composition of the obtained polymer was as follows, after drying the solvent: 1 The molecular weight (Mw) and dispersity (Mw / Mn) of the obtained polymer were confirmed by gel permeation chromatography (GPC) using tetrahydrofuran (THF) as a solvent. The ionic polymers 1 to 14 having alkoxysilyl groups thus synthesized are shown below.

[0263] Ionic Polymer 1 Mw=34,100 Mw / Mn=2.11 [ka]

[0264] Ionic Polymer 2 Mw=16,600 Mw / Mn=1.65 [ka]

[0265] Ionic Polymer 3 Mw=31,900 Mw / Mn=1.89 [ka]

[0266] Ionic Polymer 4 Mw=16,500 Mw / Mn=1.79 [ka] (The number of repetitions in the formula indicates the average value.)

[0267] Ionic Polymer 5 Mw=51,100 Mw / Mn=1.91 [ka]

[0268] Ionic Polymer 6 Mw=27,400 Mw / Mn=1.91 [ka]

[0269] Ionic Polymer 7 Mw=42,100 Mw / Mn=2.11 [ka] (The number of repetitions in the formula indicates the average value.)

[0270] Ionic Polymer 8 Mw=19,800 Mw / Mn=1.91 [ka] (The number of repetitions in the formula indicates the average value.)

[0271] Ionic Polymer 9 Mw=21,300 Mw / Mn=2.05 [ka] (The number of repetitions in the formula indicates the average value.)

[0272] Ionic Polymer 10 Mw=21,500 Mw / Mn=1.70 [ka]

[0273] Ionic Polymer 11 Mw=21,800 Mw / Mn=1.91 [ka]

[0274] Ionic Polymer 12 Mw=21,500 Mw / Mn=1.75 [ka]

[0275] Ionic Polymer 13 Mw=22,100 Mw / Mn=1.60 [ka]

[0276] Ionic Polymer 14 Mw=26,600 Mw / Mn=1.71 [ka]

[0277] Blend ionic polymer 1 and comparative ionic polymer 1 for comparison are shown below.

[0278] Blended ionic polymer 1 Mw=39,100 Mw / Mn=1.91 [ka] (The number of repetitions in the formula indicates the average value.) Comparative ionic polymer 1 Mw=26,900 Mw / Mn=1.99 [ka]

[0279] (composite silica) 5 g of dry silica (SIGMA-Aldrich, size 5-20 nm) was added to 100 g of methyl isobutyl ketone (MIBK) dried over molecular sieves and stirred for one day. 15 g of a 30 wt % cyclopentanone solution of ionic polymer 1 was then dropped into the mixture. After stirring at room temperature for 20 hours, the solvent was dried to synthesize ionic polymer 1 composite silica with ionic polymer 1 pendant thereon.

[0280] In the same manner, ionic polymer 2 composite silica to ionic polymer 12 composite silica and comparative ionic polymer 1 composite silica were synthesized.

[0281] Using a similar method, the dry silica was changed to silicon powder (Sigma-Aldrich, size 100 nm or less), silicon carbide powder (Sigma-Aldrich, size 100 nm or less), and silicon monoxide powder (Sigma-Aldrich, size 440 nm or less), and reacted with ionic polymer 13 to synthesize ionic polymer 13-composite silicon carbide powder, ionic polymer 13-composite silicon monoxide powder, and ionic polymer 13-composite silicon powder, respectively.

[0282] Using a similar method, the dry silica was changed to silicon powder (Sigma-Aldrich, size 100 nm or less), silicon carbide powder (Sigma-Aldrich, size 100 nm or less), and silicon monoxide powder (Sigma-Aldrich, size 440 nm or less), and reacted with ionic polymer 14 to synthesize ionic polymer 14 composite silicon carbide powder, ionic polymer 14 composite silicon monoxide powder, and ionic polymer 14 composite silicon powder, respectively.

[0283] Using a similar method, the dry silica was changed to aluminum oxide powder (Sigma-Aldrich, size 50 nm or less), titanium oxide powder (Sigma-Aldrich, size 100 nm or less), zirconium oxide powder (Sigma-Aldrich, size 100 nm or less), and lithium titanate powder (Sigma-Aldrich, size 200 nm or less), and reacted with ionic polymer 5 to synthesize ionic polymer 5 composite alumina oxide powder, ionic polymer 5 composite titania powder, ionic polymer 5 composite zirconia powder, and ionic polymer 5 composite lithium titanate powder, respectively.

[0284] Siloxane compounds 1 to 4 that were blended as silicone resins in the bioelectrode composition solution are shown below. (Siloxane Compound 1) The viscosity of a 30% toluene solution was 27,000 mPa·s, the alkenyl group content was 0.007 mol / 100 g, and the vinyl group-containing polydimethylsiloxane whose molecular chain ends were blocked with SiMe2Vi groups was designated as siloxane compound 1. (Siloxane Compound 2) Me3SiO 0.5 Polysiloxane (Me3SiO 0.5 A 60% toluene solution of siloxane compound 2 (SiO2 unit / SiO2 unit = 0.8) was used as the siloxane compound 2. (Siloxane Compound 3) 40 parts by mass of vinyl-containing polydimethylsiloxane whose molecular chain ends are capped with OH, whose viscosity in a 30% toluene solution is 42,000 mPa s and whose alkenyl group content is 0.007 mol / 100 g, Me3SiO 0.5 Polysiloxane (Me3SiO 0.5 A solution consisting of 100 parts by mass of a 60% toluene solution of 1,2-dichlorophenyl ether (SiO2 unit / SiO2 unit=0.8) and 26.7 parts by mass of toluene was heated under reflux for 4 hours and then cooled to obtain siloxane compound 3 in which polydimethylsiloxane was bonded to the MQ resin. (Siloxane Compound 4) As the methyl hydrogen silicone oil, KF-99 manufactured by Shin-Etsu Chemical Co., Ltd. was used.

[0285] The silicone pendant urethane acrylates 1 to 3 and urethane acrylate 1 blended in the bioelectrode composition solution are shown below. [ka] (The number of repetitions in the formula indicates the average value.)

[0286] The acrylic polymers blended as the acrylic resin in the bioelectrode composition solution are shown below. Acrylic Polymer 1 Mw=127,000 Mw / Mn=2.28 [ka] (The number of repetitions in the formula indicates the average value.)

[0287] Polyglycerin silicone compounds 1 to 8 are shown below.

[0288] [ka]

[0289] [ka]

[0290] The organic solvents contained in the bioelectrode composition solution are shown below. EDE: Diethylene glycol diethyl ether Isopar G: Isoparaffinic solvent, manufactured by Standard Oil Isopar M: Isoparaffinic solvent, manufactured by Standard Oil

[0291] The lithium titanate powder, radical generator, platinum catalyst, and conductivity enhancer (carbon black, carbon nanotubes, and metal powder) that were blended as additives in the bioelectrode composition solution are shown below. Metal powder Silver powder: Sigma-Aldrich silver flakes, diameter 10 μm Lithium titanate powder, spinel: Sigma-Aldrich, size 200nm or less Radical generator: BASF Irgacure TPO Platinum catalyst: CAT-PL-50T manufactured by Shin-Etsu Chemical Co., Ltd. Carbon black: Denka Black Li-400 manufactured by Denka Multi-walled carbon nanotubes: Sigma-Aldrich, diameter 110-170 nm, length 5-9 μm

[0292] As the silica in the comparative example, dry silica (SIGMA-Aldrich, size 5 to 20 nm) was used.

[0293] [Examples 1 to 29, Comparative Examples 1 to 4] Ionic polymer composite particles, resin, ionic polymer, organic solvent, and additives (radical generator, platinum catalyst, conductivity enhancer, etc.) were blended in the compositions shown in Tables 1 to 3 to prepare bioelectrode composition solutions (bioelectrode composition solutions 1 to 29, comparative bioelectrode composition solutions 1 to 4).

[0294] [Table 1]

[0295] [Table 2] TIFF0007577883000112.tif180168TIFF0007577883000113.tif180168TIFF0007577883000114.tif180168

[0296] [Table 3]

[0297] (Preparation of bioelectrodes) As shown in FIG. 3, a conductive paste manufactured by Fujikura Kasei, Dotite FA-333, was coated on ST-604 of a thermoplastic urethane (TPU) film 20 manufactured by Bemis by screen printing, and baked in an oven at 120°C for 10 minutes to print a keyhole-shaped conductive pattern 2 with a circle diameter of 2 cm. The bioelectrode composition solution shown in Tables 1 to 3 was applied by screen printing on the circular part on top of it, and after air drying at room temperature for 10 minutes, it was baked in an oven at 125°C for 10 minutes to evaporate the solvent and harden it to form a biocontact layer 3, and the bioelectrode 1 was obtained. Furthermore, in Examples 14 to 18, the xenon lamp was irradiated at 200 mJ / cm2 under a nitrogen atmosphere to harden it. Next, as shown in FIG. 4, the thermoplastic urethane film 20 on which the bioelectrode 1 was printed was cut out, and a double-sided tape 21 was attached to it, and three bioelectrode samples 10 were prepared for each composition solution.

[0298] (Measurement of the thickness of the biological contact layer) The thickness of the biocontact layer of the bioelectrode prepared above was measured using a micrometer. The results are shown in Table 4.

[0299] (Measurement of biological signals) The conductive wiring pattern made of conductive paste of the bioelectrode was connected with a portable electrocardiograph HCG-901 manufactured by Omron Healthcare Co., Ltd. with a conductive wire, and the positive electrode of the electrocardiograph was attached to the LA position of the human body in Figure 5, the negative electrode to the LL position, and the earth to the RA position. Immediately after attachment, electrocardiogram measurement was started, and the time until the electrocardiogram waveform (ECG signal) consisting of P, Q, R, S, and T waves shown in Figure 6 appeared was measured. The results are shown in Table 4.

[0300] [Table 4]

[0301] As shown in Table 4, in Examples 1 to 29 in which the biocontact layer was formed using the bioelectrode composition of the present invention containing a complex of an ionic polymer and particles, a biosignal could be obtained in a short time after application to the body. On the other hand, in Comparative Examples 1, 3, and 4 in which no ionic component of a specific structure was contained, a biosignal could not be obtained. In the case of Comparative Example 2 in which only an ionic polymer was added, it took a long time for a biosignal to appear after application to the skin.

[0302] From the above, a bioelectrode having a biocontact layer formed using the bioelectrode composition of the present invention has excellent electrical conductivity, biocompatibility, and adhesion to conductive substrates, and has high ionic conductivity, allowing biosignals to be obtained immediately after being attached to the skin.

[0303] The present invention is not limited to the above-described embodiment. The above-described embodiment is merely an example, and anything that has substantially the same configuration as the technical idea described in the claims of the present invention and exhibits similar effects is included in the technical scope of the present invention. [Explanation of symbols]

[0304] 1...bioelectrode, 2...conductive substrate (conductive pattern), 3...biocontact layer, 4...ionic complex, 5...blended ionic polymer, 6...adhesive resin, 7...Body, 10...Bioelectrode sample, 20...Thermoplastic urethane film, 21...Double-sided tape.

Claims

1. A polymer compound having a repeating unit having a structure selected from the group consisting of ammonium salts, lithium salts, sodium salts, potassium salts, and silver salts of N-carbonylfluorosulfonamide, and a repeating unit having an alkoxysilyl group, and having a weight average molecular weight in the range of 1,000 to 1,000,000.

2. The polymer compound according to claim 1, characterized in that the repeating unit having a structure selected from the group consisting of ammonium salts, lithium salts, sodium salts, potassium salts, and silver salts of N-carbonylfluorosulfonamide is a repeating unit a7 represented by the following general formula (5), and the repeating unit having an alkoxysilyl group is a repeating unit b represented by the following general formula (5): 【Chemistry 1】 (In the formula, R 13 are each independently a hydrogen atom or a methyl group, R 14 X each independently represents a single bond, or a linear, branched or cyclic hydrocarbon group having 1 to 13 carbon atoms which may have either an ester group or an ether group, or both. 7 each independently represents a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group; M + is an ion selected from an ammonium ion, a lithium ion, a sodium ion, a potassium ion, and a silver ion. 7 R is a fluorine atom or a linear or branched alkyl group having 1 to 4 carbon atoms and having at least one fluorine atom. 20 is a hydrogen atom or a methyl group, and X 8 is a single bond, a phenylene group, a naphthylene group, an ether group, an ester group, or an amide group; R 21 R is a single bond, a linear, branched or cyclic alkylene group having 1 to 10 carbon atoms, or a phenylene group, which may contain an oxygen atom or a nitrogen atom. 22 are the same or different alkyl groups having 1 to 4 carbon atoms. a7 is 0<a7<1.0, and b is 0<b<1.0.)

Citation Information

Patent Citations

  • Conductive millable urethane rubber electrode

    JP1993095924A

  • Silicone rubber composition for living body electrode and electrode for living body

    JP2003225217A

  • Long-life conjugated polymer electrochemical device incorporating ionic liquid

    JP2004527902A

  • Biocompatible electrode structure and manufacturing method therefor, and device and manufacturing method therefor

    JP2015019806A

  • Clothing for bioelectric signal monitor

    JP2015100673A